Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$326.30M$326.30Mderived+10.7% vs Q4 2024 Net Income$38.16M$38.16Mderived−11.7% vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Cash Flowderived$67,736,000+17.7% Free Cash Flowderived-$75,562,000N/M Margins · derivedNet margin11.7%−3.0 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 26, 2026 · 57 d after period end